To assess the specificity of CysLT1R in PITCS, co-cultures of breast cancer cells with platelets were treated with HAMI3379, a CysLT2R inhibitor, or with the CysLT1R antagonist zafirlukast. The gene discussed is CYSLTR2; the disease is breast carcinoma.